Physician profile
Tim Tytle
NPI 1639137953
$1,303.61
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $216 · 2021: $513.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $504.16 | 2019-2020 | |
| Depuy Synthes Sales INC. | $489.43 | 2019-2021 | |
| Inari Medical, INC. | $136.75 | 2020-2021 | |
| Medtronic, INC. | $32.92 | 2021 | |
| Boston Scientific Corporation | $31.04 | 2020-2021 | |
| W. L. Gore & Associates, INC. | $26.34 | 2021 | |
| Abbott Laboratories | $24.19 | 2021 | |
| Microvention, INC. | $18.13 | 2021 | |
| B. Braun Interventional Systems INC. | $15.61 | 2021 | |
| Sirtex Medical INC | $14.23 | 2020 | |
| Ekos Corporation | $10.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Tytle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.